KR100868529B1 - 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 - Google Patents
희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 Download PDFInfo
- Publication number
- KR100868529B1 KR100868529B1 KR1020047018837A KR20047018837A KR100868529B1 KR 100868529 B1 KR100868529 B1 KR 100868529B1 KR 1020047018837 A KR1020047018837 A KR 1020047018837A KR 20047018837 A KR20047018837 A KR 20047018837A KR 100868529 B1 KR100868529 B1 KR 100868529B1
- Authority
- KR
- South Korea
- Prior art keywords
- rare
- cells
- allose
- glucose
- cell
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
Claims (30)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 암세포 증식억제작용 감수성 세포, 케모카인 분비억제작용 감수성 세포, 및 혈당강하작용 감수성 세포로 이루어지는 군에서 선택되는 생리활성작용 감수성 세포에 작용하는, 암, 동맥경화증, 또는 당뇨병의 예방 또는 치료에 유효한, D-프사이코스인 희소당을 유효성분으로서 배합한 약제 조성물.
- 제 20항에 있어서,상기 세포가 인간세포인 것을 특징으로 하는 조성물.
- 삭제
- 삭제
- 삭제
- 암세포 증식억제작용 감수성 세포, 케모카인 분비억제작용 감수성 세포, 및 혈당강하작용 감수성 세포로 이루어지는 군에서 선택되는 생리활성작용 감수성 세포에 작용하는, 암, 동맥경화증, 또는 당뇨병의 예방 또는 치료에 유효한, D-프사이코스인 희소당을 유효성분으로서 배합한 기능성 식품용 조성물.
- 제 25항에 있어서,상기 세포가 인간세포인 것을 특징으로 하는 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2002-00148370 | 2002-05-22 | ||
JP2002148370 | 2002-05-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087011367A Division KR100908626B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060071825A KR20060071825A (ko) | 2006-06-27 |
KR100868529B1 true KR100868529B1 (ko) | 2008-11-12 |
Family
ID=29545235
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097005318A KR100945825B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한 조성물 |
KR1020047018837A KR100868529B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 |
KR1020087011367A KR100908626B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097005318A KR100945825B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한 조성물 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087011367A KR100908626B1 (ko) | 2002-05-22 | 2003-05-22 | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 |
Country Status (7)
Country | Link |
---|---|
US (2) | US7906487B2 (ko) |
EP (4) | EP3115052B1 (ko) |
JP (2) | JP4609845B2 (ko) |
KR (3) | KR100945825B1 (ko) |
CN (1) | CN1668735A (ko) |
AU (1) | AU2003235403A1 (ko) |
WO (1) | WO2003097820A1 (ko) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906487B2 (en) | 2002-05-22 | 2011-03-15 | Fushimi Pharmaceutical Co., Ltd. | Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
JP4053921B2 (ja) * | 2003-03-31 | 2008-02-27 | 合同会社希少糖生産技術研究所 | 希少糖によるラクトパーオキシダーゼの阻害と利用 |
JP5421512B2 (ja) * | 2004-01-30 | 2014-02-19 | 帝國製薬株式会社 | D−プシコースの血糖上昇抑制効果の利用 |
JP4724824B2 (ja) * | 2004-03-19 | 2011-07-13 | 国立大学法人 香川大学 | 希少糖のtリンパ球の増殖抑制への使用 |
JP4724823B2 (ja) * | 2004-03-19 | 2011-07-13 | 国立大学法人 香川大学 | 希少糖の神経細胞における保護作用を利用する予防薬、治療薬、特定保健用食品 |
EP1757296A4 (en) * | 2004-05-26 | 2010-09-01 | Rare Sugar Production Technica | METHOD FOR CONTROLLING THE PROLIFERATION OF TISSUE ENDHELICELLS AND INHIBITION OF LUMENING |
WO2005115409A1 (ja) * | 2004-05-26 | 2005-12-08 | National University Corporation Kagawa University | 動脈硬化症発症の抑制性組成物および抑制方法 |
EP1759582B1 (en) * | 2004-05-26 | 2016-11-23 | National University Corporation Kagawa University | Preservative solution for cells, tissues and organs comprising rare sugar and preservation method with the use of the same |
JP5171249B2 (ja) * | 2005-03-23 | 2013-03-27 | 株式会社希少糖生産技術研究所 | D−プシコースの血糖値日内異常上昇抑制の用途 |
JP5116071B2 (ja) * | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | D−アロースおよびd−プシコースの抗神経因性疼痛効果の利用 |
JP5240810B2 (ja) * | 2005-07-20 | 2013-07-17 | 帝國製薬株式会社 | D−プシコースの血中d−フラクトース濃度上昇抑制への使用 |
JP5116072B2 (ja) * | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | D−アロースの血糖上昇抑制効果の利用 |
EP1964568B1 (en) * | 2005-08-31 | 2014-03-26 | National University Corporation Kagawa University | Utilization of hypertension/hypercardia-preventing effect of d-allose |
WO2007100102A1 (ja) * | 2006-03-03 | 2007-09-07 | National University Corporation Kagawa University | 抗線虫用組成物および抗線虫性組成物を用いる線虫制圧法 |
WO2008056452A1 (fr) * | 2006-11-09 | 2008-05-15 | National University Corporation Kagawa University | Utilisation de sucre rare pour ralentir le début ou l'évolution de la mobilité réduite associée avec la sclérose latérale amyotrophique |
EP2567694B1 (en) * | 2006-11-10 | 2016-10-26 | Matsutani Chemical Industry Co., Ltd. | Non-cariogenic material and cariostatic agent containing D-sorbose |
EP2111865B1 (en) * | 2006-11-17 | 2019-10-02 | National University Corporation Kagawa University | Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm |
KR100972696B1 (ko) * | 2008-04-24 | 2010-07-27 | 경상대학교산학협력단 | 호르몬 불감성 전립선암 세포주에 아폽토시스를 유도하는알로스 |
JP2009269887A (ja) * | 2008-05-09 | 2009-11-19 | Kagawa Univ | 希少糖を含有する腹膜劣化抑制剤、腹膜透析液および腹膜透析法 |
HUE039203T2 (hu) | 2008-08-18 | 2018-12-28 | Mitsui Chemicals Agro Inc | Növénybetegség elleni szer, amely hatóanyagként tartalmaz D-tagatózt, és növénybetegség elleni védekezésre szolgáló eljárás |
WO2010113785A1 (ja) * | 2009-03-30 | 2010-10-07 | 松谷化学工業株式会社 | 目的とするヘキソースを所定量含む原料糖とは異なる糖組成の糖組成物の製造方法および製造された糖組成物の用途 |
JP5764308B2 (ja) * | 2010-09-16 | 2015-08-19 | 松谷化学工業株式会社 | 酒類およびビール風味飲料の味質の改善方法 |
JP5731784B2 (ja) * | 2010-09-29 | 2015-06-10 | 松谷化学工業株式会社 | 食感食味の優れたベーカリー製品及びその製造法 |
KR101017276B1 (ko) * | 2010-10-01 | 2011-02-25 | 서운교 | 뽕나무에서 유래되는 호흡기 질환 치료용 약학조성물 |
JP5787340B2 (ja) * | 2010-11-05 | 2015-09-30 | 国立大学法人 香川大学 | 破骨細胞分化抑制組成物 |
JP6216493B2 (ja) | 2011-06-24 | 2017-10-18 | 国立大学法人 香川大学 | 寿命延長剤 |
JP6013712B2 (ja) * | 2011-09-06 | 2016-10-25 | 合同会社希少糖食品 | D−プシコースを有効成分とする生体代謝パラメーター改善剤 |
JP2014529994A (ja) * | 2011-09-15 | 2014-11-17 | シージェイ チェイルジェダング コーポレイション | 遅消化性成分を含有する糖尿改善用甘味素材組成物 |
PL2756764T3 (pl) * | 2011-09-15 | 2018-03-30 | Cj Cheiljedang Corp | Kompozycja środka słodzącego do zapobiegania i zmniejszania otyłości, zawierająca składnik będący inhibitorem glikolizy |
KR101307947B1 (ko) * | 2011-11-30 | 2013-09-12 | 씨제이제일제당 (주) | 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제 |
GB201309079D0 (en) | 2013-03-15 | 2013-07-03 | Tate & Lyle Ingredients | Improved sweetner |
GB201309076D0 (en) | 2013-03-15 | 2013-07-03 | Tate & Lyle Ingredients | Improved sweetener |
GB201309077D0 (en) | 2013-03-15 | 2013-07-03 | Tate & Lyle Ingredients | Improved sweetener |
CN105101815B (zh) * | 2013-04-08 | 2017-07-28 | 松谷化学工业株式会社 | 饮食物的咸味增强方法以及利用该方法所得的饮食物及咸味增强剂 |
CN105188709A (zh) | 2013-04-26 | 2015-12-23 | 松谷化学工业株式会社 | 能量消耗的促进和/或能量消耗功能降低的治疗和/或预防剂、或者方法 |
JP6391959B2 (ja) * | 2014-03-26 | 2018-09-19 | 公立大学法人福岡女子大学 | 非アルコール性脂肪性肝炎の改善剤および改善用栄養組成物 |
EP3171710A1 (en) | 2014-07-21 | 2017-05-31 | Roquette Frères | Sugar compositions for tableting by direct compression |
KR102557664B1 (ko) * | 2014-07-21 | 2023-07-20 | 로께뜨프레르 | 직접 압축에 의한 타정을 위한 당 조성물 |
JPWO2016152293A1 (ja) * | 2015-03-20 | 2018-03-01 | 国立大学法人 香川大学 | 癌細胞のglut1の発現抑制用組成物および発現抑制方法 |
WO2017018500A1 (ja) * | 2015-07-29 | 2017-02-02 | 学校法人 自治医科大学 | Glp-1分泌促進剤 |
JP6948670B2 (ja) * | 2017-06-29 | 2021-10-13 | 松谷化学工業株式会社 | D−プシコース及び大豆たんぱく質を有効成分とする生体機能改善用組成物 |
JP7102007B2 (ja) | 2018-01-26 | 2022-07-19 | 松谷化学工業株式会社 | 自閉症スペクトラム障害及び精神疾患改善剤 |
CN109528554A (zh) * | 2018-12-10 | 2019-03-29 | 珀莱雅化妆品股份有限公司 | 一种抗皱组合物及其巴布剂的制备方法 |
US20220152068A1 (en) * | 2019-03-20 | 2022-05-19 | National University Corporation Kagawa University | Drug delivery carrier utilizing property of d-allose being uptaken by cancer cell, drug delivery method, and composition for treating renal cell carcinoma |
US20220184105A1 (en) * | 2019-03-26 | 2022-06-16 | National University Corporation Kagawa University | Pharmaceutical composition injectable into urinary tract organ cavity for prevention or treatment of urothelial cancer |
JPWO2020203086A1 (ko) * | 2019-03-29 | 2020-10-08 | ||
WO2021193659A1 (ja) | 2020-03-23 | 2021-09-30 | 国立大学法人 香川大学 | D-アロースを有効成分として含む、腎細胞癌を治療又は予防するための組成物、及びそれを用いた癌を治療又は予防する方法 |
EP4130278A1 (en) | 2020-03-26 | 2023-02-08 | National University Corporation Kagawa University | Novel l-rhamnose isomerase |
JP7449511B2 (ja) | 2020-05-22 | 2024-03-14 | 松谷化学工業株式会社 | 加齢に伴う認知機能の低下予防又は改善用の組成物 |
CN116783300A (zh) | 2020-11-30 | 2023-09-19 | 国立大学法人香川大学 | 新型l-鼠李糖异构酶 |
WO2023136329A1 (ja) * | 2022-01-14 | 2023-07-20 | 国立大学法人 香川大学 | 細胞増殖遅延剤、それを含む化粧品、及び細胞増殖を遅延させる方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620960A (en) | 1994-08-15 | 1997-04-15 | Uop | Use of D-allose as an immunosuppressive agent |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429716A (en) * | 1967-05-10 | 1969-02-25 | Frederick A Andrews | Oxidation resistant compositions for human consumption |
JPS57129671A (en) | 1981-02-05 | 1982-08-11 | Biospherics Inc | Sweetened edible compound |
JPS63198630A (ja) | 1987-02-13 | 1988-08-17 | Kao Corp | 脂質代謝改善剤 |
JPH01149730A (ja) * | 1987-12-07 | 1989-06-12 | Osaka Prefecture | レトロウイルス増殖抑制剤 |
US4963382A (en) * | 1989-06-22 | 1990-10-16 | Allied-Signal Inc. | Reduced calorie D-aldohexose monosaccharides |
JP2787252B2 (ja) | 1991-06-17 | 1998-08-13 | 雪印乳業株式会社 | 大腸癌抑制剤 |
JPH057619A (ja) * | 1991-06-24 | 1993-01-19 | L Lyndstrom Richard | 血清不含医療用規定溶液およびその溶液を用いた角膜の保存方法 |
JPH06199696A (ja) * | 1992-03-06 | 1994-07-19 | Yunie:Kk | 制癌・抗癌剤 |
JP3333969B2 (ja) | 1992-10-08 | 2002-10-15 | 株式会社林原生物化学研究所 | D−ケトヘキソース・3−エピメラーゼとその製造方法並びに用途 |
JP3095605B2 (ja) * | 1994-02-04 | 2000-10-10 | 明治製菓株式会社 | 抗酸化物質を含有する健康飲食品および抗酸化物質の製造法 |
JPH07285871A (ja) | 1994-04-18 | 1995-10-31 | Mikimoto Pharmaceut Co Ltd | 活性酸素抑制剤 |
US5908782A (en) * | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
EP0891419A4 (en) * | 1996-03-12 | 2000-03-01 | Life Technologies Inc | NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES |
JPH10330268A (ja) | 1997-05-26 | 1998-12-15 | Kureha Chem Ind Co Ltd | ピラノピラノン化合物含有hsp47合成抑制剤 |
JP2000007550A (ja) * | 1998-06-19 | 2000-01-11 | Shiseido Co Ltd | 皮膚外用剤 |
JP2000103728A (ja) * | 1998-07-28 | 2000-04-11 | Shiseido Co Ltd | 皮膚バリア―機能回復促進剤 |
JP3587701B2 (ja) * | 1998-10-05 | 2004-11-10 | ポーラ化成工業株式会社 | 保湿用の組成物及びそれを含有する皮膚外用の組成物 |
JP2002529071A (ja) * | 1998-11-09 | 2002-09-10 | コンソルツィオ・ペール・ラ・ジェスティオーネ・デル・チェントロ・ディ・ビオテクノロジー・アヴァンツァテ | 軟骨細胞様細胞のための無血清培地 |
US6051236A (en) * | 1998-11-12 | 2000-04-18 | Pacifichealth Laboratories, Inc. | Composition for optimizing muscle performance during exercise |
AU771984B2 (en) * | 1998-12-22 | 2004-04-08 | University Of North Carolina At Chapel Hill, The | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
DE19932197A1 (de) * | 1999-07-09 | 2001-01-18 | Neudecker Birgit | Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung |
JP4344048B2 (ja) * | 1999-08-03 | 2009-10-14 | 株式会社川島製作所 | 袋包装装置 |
US6608042B2 (en) * | 2000-03-28 | 2003-08-19 | Aventis Pharma, S.A. | Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof |
FR2809003B1 (fr) * | 2000-05-18 | 2003-01-24 | Oreal | Compositions anti-pollution a base d'anthocyanes |
JP4499882B2 (ja) | 2000-07-07 | 2010-07-07 | 株式会社林原生物化学研究所 | D−キシロース・イソメラーゼを用いるアルドヘキソースの製造方法 |
US6355409B1 (en) * | 2000-09-01 | 2002-03-12 | Biospherics Incorporated | Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury |
US7196071B2 (en) * | 2000-09-20 | 2007-03-27 | The General Hospital Corporation | Methods of decreasing or preventing pain using spicamycin derivatives |
JP2003095826A (ja) | 2001-09-21 | 2003-04-03 | Sumitomo Chem Co Ltd | 害虫防除材 |
JP2003095828A (ja) | 2001-09-27 | 2003-04-03 | Shinto Fine Co Ltd | 工業用抗菌組成物及び抗菌方法 |
US7906487B2 (en) | 2002-05-22 | 2011-03-15 | Fushimi Pharmaceutical Co., Ltd. | Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
CA2444161A1 (en) * | 2003-10-01 | 2005-04-01 | Japan Health Sciences Foundation | A screening method of drug for treatment of neuropathic pain |
-
2003
- 2003-05-22 US US10/515,018 patent/US7906487B2/en active Active
- 2003-05-22 KR KR1020097005318A patent/KR100945825B1/ko active IP Right Grant
- 2003-05-22 CN CNA038172313A patent/CN1668735A/zh active Pending
- 2003-05-22 EP EP16183213.4A patent/EP3115052B1/en not_active Expired - Lifetime
- 2003-05-22 KR KR1020047018837A patent/KR100868529B1/ko active IP Right Grant
- 2003-05-22 KR KR1020087011367A patent/KR100908626B1/ko active IP Right Grant
- 2003-05-22 EP EP17150941.7A patent/EP3175858B1/en not_active Expired - Lifetime
- 2003-05-22 WO PCT/JP2003/006405 patent/WO2003097820A1/ja active Application Filing
- 2003-05-22 EP EP11169415.4A patent/EP2364710B1/en not_active Expired - Lifetime
- 2003-05-22 EP EP03752940.1A patent/EP1538200B1/en not_active Expired - Lifetime
- 2003-05-22 JP JP2004506478A patent/JP4609845B2/ja not_active Expired - Lifetime
- 2003-05-22 AU AU2003235403A patent/AU2003235403A1/en not_active Abandoned
-
2009
- 2009-12-07 JP JP2009277930A patent/JP5330976B2/ja not_active Expired - Lifetime
-
2011
- 2011-01-14 US US13/007,058 patent/US8420606B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620960A (en) | 1994-08-15 | 1997-04-15 | Uop | Use of D-allose as an immunosuppressive agent |
Also Published As
Publication number | Publication date |
---|---|
WO2003097820A1 (fr) | 2003-11-27 |
EP1538200A1 (en) | 2005-06-08 |
EP1538200B1 (en) | 2017-04-05 |
EP3175858A1 (en) | 2017-06-07 |
KR100945825B1 (ko) | 2010-03-05 |
CN1668735A (zh) | 2005-09-14 |
US7906487B2 (en) | 2011-03-15 |
JP2010059200A (ja) | 2010-03-18 |
US20050245459A1 (en) | 2005-11-03 |
EP2364710A1 (en) | 2011-09-14 |
JPWO2003097820A1 (ja) | 2005-09-15 |
KR20080053407A (ko) | 2008-06-12 |
KR100908626B1 (ko) | 2009-07-21 |
KR20090032147A (ko) | 2009-03-31 |
AU2003235403A8 (en) | 2003-12-02 |
EP3115052A1 (en) | 2017-01-11 |
JP4609845B2 (ja) | 2011-01-12 |
AU2003235403A1 (en) | 2003-12-02 |
EP3175858B1 (en) | 2019-08-21 |
EP2364710B1 (en) | 2018-11-28 |
EP3115052B1 (en) | 2019-08-21 |
EP1538200A4 (en) | 2007-06-06 |
US8420606B2 (en) | 2013-04-16 |
KR20060071825A (ko) | 2006-06-27 |
US20110112043A1 (en) | 2011-05-12 |
JP5330976B2 (ja) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100868529B1 (ko) | 희소당의 생리활성 작용의 이용방법 및 희소당을 배합한조성물 | |
US20100222285A1 (en) | Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation | |
US20110038959A1 (en) | Plant-origin drug for preventing or improving hyperuricemia | |
JPH09176019A (ja) | 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品 | |
WO2007010976A1 (ja) | D-プシコースを含有する体重増加抑制性組成物およびその利用方法 | |
JP5116072B2 (ja) | D−アロースの血糖上昇抑制効果の利用 | |
JP4520089B2 (ja) | ルブロフサリン配糖体含有組成物 | |
KR102605627B1 (ko) | 류신 유도체, 이를 포함하는 조성물 및 이의 용도 | |
JP2013032366A (ja) | α−グリコシルヘスペリジンを含有する経口投与・摂取用の皮脂量低下抑制剤 | |
JP7398207B2 (ja) | Toxic AGEs生成抑制剤 | |
KR100468073B1 (ko) | 함초 추출물 또는 이로부터 분리된이소람네틴-3-O-β-D-글루코시드를 포함하는 조성물 | |
KR100867370B1 (ko) | 고삼 추출물 또는 이로부터 분리한 5-메틸소포라플라바논b를 유효성분으로 함유하는 당뇨병 합병증 또는 비만의예방 및 치료용 약학적 조성물 | |
KR102588274B1 (ko) | D-리모넨을 유효성분으로 포함하는 뇌전증 또는 발작 관련 질환의 예방 또는 치료용 약제학적 조성물 | |
CN115590874A (zh) | 锦葵素-3-o-葡萄糖苷在制备药物或保健食品的应用 | |
KR20230026799A (ko) | 함초 추출물 또는 이로부터 분리된이소람네틴-3-O-β-D-글루코시드를 포함하는 조성물 | |
KR20230033488A (ko) | 칠엽수 추출물을 포함하는 조성물 | |
KR101348411B1 (ko) | 브란디오사이드 또는 페리포사이드를 포함하는 당뇨합병증의 치료 또는 예방용 또는 항노화용 조성물 | |
KR20180000079A (ko) | Kahweol을 포함하는 항비만 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
N231 | Notification of change of applicant | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E90F | Notification of reason for final refusal | ||
A107 | Divisional application of patent | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120822 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130820 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141024 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151030 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20171027 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20181029 Year of fee payment: 11 |